The largest community for pharma industry

Featured

Coronavirus outbreak begins to disrupt booming China drug trials

(Reuters) - The fast-spreading coronavirus is starting to disrupt testing of experimental medicines in China, posing a threat to plans by global drugmakers that...

Life Sciences Industry Rapidly Adopting Real-World Data, but Access to Robust Data a Concern/Barrier, According to Inteliquet Survey

DOVER, Del.--(BUSINESS WIRE)--Inteliquet, a leading provider of intelligent technology, advanced insights, and expertise for clinical research, patient treatment and translational medicine, announced findings of...

Trump says U.S. has ‘shut down’ coronavirus threat; China shuns U.S. help

WASHINGTON (Reuters) - The United States has taken decisive action to protect Americans from the threat of a fast-moving coronavirus while offering help to...

Cocktail of flu, HIV drugs appears to help fight coronavirus: Thai doctors

BANGKOK (Reuters) - Thai doctors have seen success in treating severe cases of the new coronavirus with combination of medications for flu and HIV,...

Trump and Trudeau discussed coronavirus in Friday phone call

WASHINGTON (Reuters) - U.S. President Donald Trump and Canadian Prime Minister Justin Trudeau discussed their countries’ efforts to monitor, contain, and mitigate the rapidly...

“Go-to-Market”: Medical Affairs, Strategies and Timings

“Go-to-Market” in Pharma is defined as a tactical action plan, that outlines the needed steps to succeed in a new market/therapeutic area. A “Go-to-Market” strategy...

Bayer wins EU recommendation for prostate cancer drug

FRANKFURT (Reuters) - Bayer on Friday won an endorsement from the European Union’s drug regulator for its prostate cancer drug darolutamide, putting it on...

Merck’s Keytruda wins U.S. FDA approval for bladder cancer

(Reuters) - The U.S. Food and Drug Administration said on Wednesday it approved Merck & Co Inc’s Keytruda for the treatment of a type...

Field Medical Affairs In Pharma/Biotech: Effectiveness, Opportunities and Challenges

  Medical Affairs has risen very fast in the last years, becoming after an initial phase of “supporting function”, a highly crucial “leading function”, representing...

The Zeigarnik Effect – What is it and how can it help increase productivity?

As I discussed in my recent webinar on the power of habit, habits, whether conscious or subconscious, are the cause of about 40-45% of...

Merck Announces FDA Approval for ERVEBO® (Ebola Zaire Vaccine, Live)

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has...

Canadian drug distributors say no to Trump import plan

TORONTO (Reuters) - Many of Canada’s drug suppliers cannot, or will not, agree to ship cheaper prescription medicines into the United States, a new...

Recent Featured Articles

Bien-Etre Labs Achieves Seven Million Dollars ($7M) Investment Funding

HIGH POINT, N.C.--(BUSINESS WIRE)--Bien-Etre Labs, (www.bienetre.com) a nutraceutical research, discovery and development company focusing on pre- and probiotic products to regulate the human biome,...

Merck Announces Appointment of Organon & Co. General Counsel

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of Deborah H. Telman as General...

ProteinQure Collaborates with AstraZeneca to Design Novel Peptide Therapeutics

TORONTO--(BUSINESS WIRE)--ProteinQure, a leader in computational protein drug discovery, announces a collaboration with the global biopharmaceutical company AstraZeneca to apply structure-based design to the...

LGC Acquires The Native Antigen Company, Strengthening its Offer to the IVD Sector

LONDON & OXFORD, England--(BUSINESS WIRE)--Today, LGC announced the acquisition of The Native Antigen Company (NAC), one of the world’s leading suppliers of high quality...

Stoke Therapeutics Announces Publication of Data in the Journal Nature Communications That Support the Company’s Proprietary Approach to Addressing Severe Genetic Diseases by Precisely...

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of severe genetic diseases, today...